国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

《国家中心数据管理与共享系统操作说明书 —— 研究者部分》

Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack

第一作者：Hongyu Zhou,Anxin Wang

通讯作者：Yongjun Wang

albumin ischemic stroke transient ischemic attack prognosis

基本信息

2021-02-25

已发表文章

发表杂志：Stroke and Vascular Neurology

发表类型: Original Contributions

影响因子(IF): 4.081

PMID: 33632730 Pubmed原文链接 全文下载

主要研究背景及目的

Low serum albumin is an independent predictor of poor prognosis in ischemic cardio-cerebrovascular disease1, 2. Meanwhile, several studies suggested that high serum albumin may be neuroprotective in ischemic stroke in humans3, 4. It may be related to the physiological properties of serum albumin, such as anti-inflammation, antioxidation, anticoagulation, anti-platelet aggregation activity and colloid permeability5. We aimed to confirm the relationship between plasma albumin and the prognosis of ischemic cerebrovascular disease, and try to analyze the etiology and biological pathway.

方法

We analyzed data from the Third China National Stroke Registry (CNSR-Ⅲ). Patients were divided into four groups based on serum albumin levels at admission. The outcomes included poor functional outcome (mRS of 3 to 6) and mortality at 3 months and 1 year. Multiple logistic regression models and Cox regression models were used to evaluate the association, respectively. We used a fixed-effect model to calculate the risk ratio for poor functional outcome, and a random-effect model for mortality in the meta-analysis.

结论

Low serum albumin levels predict poor functional outcome and mortality in patients with AIS or TIA.

主要结果

A total of 13618 patients were enrolled. During the 3-mo follow-up period, compared with 40 to 44.9 g/L group, patients in < 35g/L group had an increased risk of poor functional outcome and mortality (adjusted OR 1.37 (95%CI 1.12 to1.67); adjusted HR 2.13 (95%CI 1.41 to 3.23)). The relationship in per 10 g/L decreased serum albumin with prognosis was consistently inversed (adjusted OR 1.17 (95%CI 1.01 to 1.35); adjusted HR 1.86 (95%CI 1.30 to 2.64)). Also, low serum albumin levels were independently correlated with clinical outcomes at 1 year. In the meta-analysis, the OR for poor functional outcome pooled 3 studies per 1 g/L decrease was 1.03 (95% CI 1.02 to 1.05), and the HR for mortality pooled 5 studies was 1.07 (95% CI 1.03 to 1.11).